Cardiovascular Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Disease stocks.

Cardiovascular Disease Stocks Recent News

Date Stock Title
Nov 20 JNJ Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China
Nov 19 JNJ Large caps in trouble? Key takeaways from Tommy Tuberville's latest trades
Nov 19 JNJ Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive
Nov 19 AMRN After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)
Nov 19 JNJ Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting
Nov 19 AMRN Top 3 Health Care Stocks You'll Regret Missing In Q4
Nov 19 JNJ J&J pill clears skin in two late-stage psoriasis studies
Nov 19 JNJ Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
Nov 18 JNJ J&J unveils positive phase 3 results for icotrokinra for plaque psoriasis
Nov 18 JNJ Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results
Nov 18 JNJ Johnson & Johnson (JNJ) Management presents at Stifel 2024 Healthcare Conference (Transcript)
Nov 18 JNJ How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
Nov 18 JNJ Johnson & Johnson appoints CIO to lead business technology strategy
Nov 18 JNJ CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC
Nov 18 JNJ Eli Lilly follows J&J in suing Biden administration over 340B rebates
Nov 16 CDIO Cardio Diagnostics Holdings Third Quarter 2024 Earnings: Misses Expectations
Nov 15 JNJ U.S. Pharma is largely immune from 'MAHA' impact: Wolfe
Nov 15 JNJ Johnson & Johnson (JNJ) Guggenheim Global Healthcare Conference (Transcript)
Nov 15 JNJ Medtech shouldn't be greatly impacted by RFK Jr. at HHS, Wells Fargo says
Nov 15 JNJ Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program
Cardiovascular Disease

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that 90% of CVD is preventable. Prevention of atherosclerosis involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Disease onset is typically seven to ten years earlier in men as compared to women.

Browse All Tags